Bruker Corp (BRKR, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels. Bruker Corp has a market cap of $5.68 billion; its shares were traded at around $36.87 with a P/E ratio of 23.34 and P/S ratio of 2.86. The dividend yield of Bruker Corp stocks is 0.43%. Bruker Corp had annual average EBITDA growth of 6.80% over the past ten years.
For the last quarter Bruker Corp reported a revenue of $599.9 million, compared with the revenue of $553.6 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $2.1 billion, an increase of 9.3% from last year. For the complete 30-year financial data, please go here.. For the last five years Bruker Corp had an average revenue growth rate of 3.6% a year.
The reported diluted earnings per share was $1.954 for the year, an increase of 71.4% from previous year. Over the last five years Bruker Corp had an EPS growth rate of 33.7% a year. The Bruker Corp had a decent operating margin of 14.52%, compared with the operating margin of 14.17% a year before. The 10-year historical median operating margin of Bruker Corp is 11.13%. The profitability rank of the company is 8 (out of 10).
At the current stock price of $36.87, Bruker Corp is traded at 36.2% premium to its historical median P/S valuation band of $27.08. The P/S ratio of the stock is 2.86, while the historical median P/S ratio is 2.08. The stock lost 2.32% during the past 12 months.
For the complete 20-year historical financial data of BRKR, click here.
